Sudarshan Pharma Industries Limited
SUDARSHAN · NSE · ₹33 a share (close of 13 Nov 2026)
Available company data, source links and archived checks for Sudarshan Pharma Industries Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Net profit was ₹7.78 crore.
Quarter ended 2026-09-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Sep 2026 | Revenue: ₹217 cr | — | Net profit: ₹8 cr | — | 3.6% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Filing timeline — what the company told the exchange
- Sudarshan Pharma Industries Limited has informed the Exchange about Resignation of Director/KMP/SMP
Company disclosure · 12 Nov 2026 · document
- Sudarshan Pharma Industries Limited has informed the Exchange regarding Resignation of Mr Nirav Shah as Company Secretary & Compliance Officer of the company w.
Company disclosure · 09 Nov 2026 · document
- Sudarshan Pharma Industries Limited has informed the Exchange about Resignation of Director/KMP/SMP
Company disclosure · 09 Nov 2026 · document
- Sudarshan Pharma Industries Limited has informed the Exchange about General Updates
Company disclosure · 07 Nov 2026 · document
- Sudarshan Pharma Industries Limited has informed the Exchange about Copy of Newspaper Publication
Company disclosure · 06 Nov 2026 · document
- Issue of Securities. Sudarshan Pharma Industries Limited has informed the Exchange about issue of Securities - In continuation of the Company''s letter dated 30
Company disclosure · 30 Oct 2026 · document
- Issue of Securities. Sudarshan Pharma Industries Limited has informed the Exchange about issue of Securities
Company disclosure · 30 Oct 2026 · document
- Integrated Filing- Financial. We are submitting herewith the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/Sep/2026
Company disclosure · 29 Oct 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time